Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial

por Kim, Seung Tae, Oh, Sung Yong, Lee, Jeeyun, Kang, Jung Hun, Lee, Hyun Woo, Lee, Myung Ah, Sohn, Byeong Seok, Hong, Ji Hyong, Park, Young Suk, Park, Joon Oh, Lim, Ho Yeong
Publicado 2019